What it’s essential to know:

– Mevo, a digital prescription platform in Brazil, at this time introduced it has raised $19 million in Sequence B funding.

– The funding spherical was led by Matrix, with participation from Jefferson River Capital (former Blackstone President and present Costco Chairman, Tony James’ household workplace), and present traders Floating Level and IKJ Capital. Notable new traders embody Elliot Cohen, former chief of Amazon Pharmacy and co-founder of PillPack.

Remodeling the Prescription Panorama

Mevo was based in 2017 with the imaginative and prescient of turning into the e-prescription infrastructure in Brazil, the place greater than 150 million individuals nonetheless depend on handwritten prescriptions. The corporate’s user-friendly cellular platform allows sufferers to simply entry and buy drugs, bettering medicine adherence and the general affected person expertise.

Enhancing affected person outcomes

Earlier than Mevo, Brazil’s prescribing system was fully paper-based, contributing to unfilled prescriptions and poor affected person outcomes. Mevo’s expertise allows healthcare suppliers to jot down digital prescriptions that sufferers can use at any pharmacy, together with Mevo’s personal market. With over 10 million sufferers already benefiting from Mevo prescriptions, the platform has achieved broad adoption throughout all Brazilian pharmacies.

Seamless and environment friendly entry to medicines

Mevo simplifies the method of buying drugs. With a Mevo e-prescription, sufferers can buy drugs in simply three clicks and obtain them through supply from Mevo’s pharmacy companions or select their favourite pharmacy in roughly 60 minutes. This flexibility and ease of use are designed to enhance medicine adherence and general affected person care.

Strengthening the healthcare ecosystem

Mevo integrates with well being info techniques, digital medical data, telemedicine platforms and healthcare suppliers. It has established greater than 250 B2B partnerships in all 26 Brazilian states and the Federal District, serving each the private and non-private healthcare sectors.

Mevo's platform presents advantages to all stakeholders within the healthcare ecosystem:

• Sufferers: Digital prescriptions and straightforward medicine ordering enhance medicine adherence and remedy outcomes.
• Healthcare professionals: Medical assist instruments cut back paperwork and drugs errors. Research have proven a 33% discount in dangerous drug interactions with Mevo's platform.
• Healthcare suppliers: Entry to structured digital prescription knowledge allows improved affected person service and real-time info evaluation.

Future plans

The brand new funding will permit Mevo to increase its community of healthcare suppliers, enhance its platform and supply further healthcare providers past simply offering prescriptions.

“This funding will permit us to increase our community and introduce new product choices that can proceed to enhance the shopper expertise,” mentioned Pedro Dias, CEO and co-founder of Mevo. “We’re centered on offering Brazilians with a greater method to entry healthcare. Mevo already serves thousands and thousands of individuals and we see a path for everybody within the nation to handle their healthcare wants from their cellular units, with security and comfort.”